Physician profile
John Michael Horn
NPI 1326008772
$1,084.64
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $497 · 2020: $194 · 2021: $87.55 · 2022: $306.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $155.94 | 2019 | |
| Zimmer Biomet Holdings, INC. | $130.83 | 2022 | |
| Pfizer INC. | $112.98 | 2019-2022 | |
| Novo Nordisk INC | $72.98 | 2019-2022 | |
| Glaxosmithkline, LLC. | $72.96 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $72.74 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $62.41 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $55.16 | 2022 | |
| Sunovion Pharmaceuticals INC. | $47.32 | 2019 | |
| Astellas Pharma US INC | $44.29 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $39.18 | 2019-2020 | |
| Allergan, INC. | $36.24 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $35.38 | 2019-2022 | |
| Lilly USA, LLC | $31.40 | 2019-2020 | |
| Shire North American Group INC | $17.54 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $16.53 | 2022 | |
| Sanofi-Aventis U.S. LLC | $15.10 | 2020 | |
| Pacira Therapeutics, INC. | $13.76 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.65 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $13.47 | 2021 | |
| Amgen INC. | $12.94 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.84 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Horn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.